drugset / Trial / NCT00472446

Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial

NCT00472446 ↗

Phase 2/3 Completed 183 enrolled Cantonal Hospital of St. Gallen
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The study investigates the impact on post-operative pain of the superficial cervical block with bupivacaine combined with subcutaneous infiltration of the incisional area in thyroid surgery under general anesthesia. In addition, cost savings using the cervical block are evaluated (due to reduced length of hospital stay). The study is prospective, randomized, double blind, and placebo-controlled. The study is performed at the Department of Surgery, Cantonal Hospital of St. Gallen.

Timeline

Start
2006-01
Primary completion
2008-12
Completion
2008-12

Outcome

Met primary endpoint

paper The bupivacaine group had significantly less pain than the placebo group (P = 0.016). PMID 20632263 ↗

registry analysis (superiority or other test); Cervivcal Block Before Surgery vs Cervivcal Block After Surgery vs Placebo Cervivcal Block Before Surgery vs Placebo Cervivcal Block After Surgery; p = .028; t-test, 2 sided NCT00472446 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 5 % Subcutaneous
Subject Bupivacaine Other / unclassified 10 ml Subcutaneous

Indications

No indication recorded.